Adeza to Present at UBS Global Life Sciences Conference
20 9월 2005 - 5:00PM
Business Wire
Adeza (NASDAQ: ADZA) today announced that Emory V. Anderson,
president and chief executive officer, will make an investment
community presentation at the UBS Global Life Sciences Conference
on Tuesday, September 27 at 11:30 a.m. Eastern Time (8:30 a.m.
Pacific Time). The conference is being held at the Grand Hyatt
Hotel in New York City. A live audio webcast of the presentation
will be available via the Internet by visiting the Investors
section of the company's Web site at www.adeza.com. An archived
presentation will be available on the Web site for 14 days. About
Adeza Adeza designs, manufactures and markets innovative products
for women's health. Adeza's initial focus is on reproductive
healthcare, using its proprietary technologies to predict preterm
birth and assess infertility. Adeza's principal product is a
patented diagnostic test, FullTerm(TM), The Fetal Fibronectin Test,
which utilizes a single-use, disposable cassette and is analyzed on
Adeza's patented TLiIQ(R) System. This product is approved by the
U.S. Food and Drug Administration (FDA) for use in assessing the
risk of preterm birth. Adeza also markets and sells the
E-tegrity(R) Test, an infertility-related test to assess
receptivity of the uterus to embryo implantation in women with
unexplained infertility. More information is available at
www.adeza.com. Adeza cautions you that statements included in this
press release that are not a description of historical facts may be
forward-looking statements. The inclusion of forward-looking
statements should not be regarded as a representation by Adeza that
any of its plans will be achieved. Actual results may differ
materially from those set forth in this release due to the risks
and uncertainties inherent in Adeza's business including, without
limitation, statements about the expansion of the indications for
its products. All forward-looking statements are qualified in their
entirety by this cautionary statement and Adeza undertakes no
obligation to revise or update this news release to reflect events
or circumstances after the date hereof.
Adeza (NASDAQ:ADZA)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Adeza (NASDAQ:ADZA)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Adeza Biomedical (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Adeza News Articles